Company Filing History:
Years Active: 1999-2007
Title: Lance Ehren: Innovator in Pain Management Technology
Introduction
Lance Ehren is a notable inventor based in Dallas, TX (US), recognized for his contributions to pain management technology. With a total of 4 patents, Ehren has made significant strides in developing innovative solutions that enhance patient care.
Latest Patents
One of Ehren's latest patents is the "Multiprogrammable Tissue Stimulator and Method." This electronic stimulation system is designed to control pain across multiple regions of a patient's body. The system incorporates one or more percutaneous leads, each equipped with multiple electrodes, which are implanted within the patient's epidural space parallel to the spinal cord. These leads connect to either a fully implanted system or a radio frequency system. The technology allows for the treatment of pain by simultaneously stimulating the patient with at least three different stimulation settings. This 'simultaneous' stimulation method involves sequentially applying multiple stimulation settings, enabling the patient to experience the cumulative effects without perceiving the transitions between settings.
Career Highlights
Ehren's career is marked by his dedication to advancing medical technology. His work at Advanced Neuromodulation Systems, Inc. has positioned him as a leader in the field of neuromodulation. His innovative approaches have not only contributed to the development of effective pain management solutions but have also improved the quality of life for many patients.
Collaborations
Ehren collaborates with talented professionals in his field, including coworkers Jay Law and William Borkan. Their combined expertise fosters an environment of innovation and creativity, driving advancements in pain management technologies.
Conclusion
Lance Ehren's contributions to the field of pain management through his innovative patents and collaborative efforts highlight his commitment to improving patient care. His work continues to pave the way for future advancements in medical technology.